Evidence map›Paper›PMID 41894493›Full record

ArticleScience advances2026

Stage-specific epigenetic priming amplifies gene activation during lineage commitment.

Arion Foertsch, Naama Hirsch, Janine Seyfferth, Ward Deboutte, Herbert Holz, Maria Shvedunova, Remzi Karayol, Thomas Stehle, Laura Arrigoni, Niyazi Umut Erdogdu and 1 more

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Arion FoertschMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.ORCID 0000-0003-0409-6209
Naama HirschMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Janine SeyfferthMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.ORCID 0009-0003-0564-7807
Ward DeboutteMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.ORCID 0000-0002-3829-1056
Herbert HolzMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
Maria ShvedunovaMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.ORCID 0000-0003-3761-4535
Remzi KarayolMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.ORCID 0000-0003-3740-9611
Thomas StehleMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.ORCID 0009-0002-0045-0506
Laura ArrigoniMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.ORCID 0000-0002-3626-4468
Niyazi Umut ErdogduMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.ORCID 0000-0001-7383-8953
Asifa AkhtarMax Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.ORCID 0000-0001-8973-6193

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neural progenitor cells exhibit developmental plasticity as they can commit to distinct developmental trajectories. The male-specific lethal complex (MSLc) is linked to multiple developmental disorders, suggesting a role in neural fate commitment. To dissect MSLc function, we used a multipronged approach combining chronic and acute depletion models. Knockout of the MSLc scaffolding component MSL1 caused embryonic lethality by E10.5 (embryonic day 10.5), and single-cell multiomics revealed altered cell population composition across multiple germ layer-derived lineages, including neuroectoderm. Two-dimensional directed differentiation models showed that the MSLc facilitates accessibility at regulatory elements during early stages of neurogenesis. Neurodevelopmental genes displayed reduced enhancer-promoter contacts and failed to reach appropriate expression levels when the MSLc was absent early in neural differentiation. In contrast, MSLc loss at later stages did not recapitulate this phenotype, indicating that MSLc-mediated gene priming is a key mechanism enabling timely activation of lineage-specifying transcriptional programs.

Indexed as

Cell LineageEpigenesis, GeneticGene Expression Regulation, DevelopmentalTranscriptional ActivationAnimalsCell DifferentiationMiceNeural Stem CellsNeurogenesisPromoter Regions, Genetic

Identifiers

PMID41894493
PMCPMC13025117

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.